Latest stories on CLDI
Calidi Biotherapeutics to Present New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026
Business Insider58 · neutralproduct/pr
Calidi Biotherapeutics to Present New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026
GlobeNewswire58 · neutralproduct/pr
Calidi Biotherapeutics, Inc. (CLDWW) files 8-K
SEC 8-K28 · bearishgeneral
Calidi Biotherapeutics gets NYSE compliance warning but stock surprises
Seeking Alpha38 · neutralgeneral
Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency
Business Insider28 · bearishgeneral
Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency
StockTitan28 · bearishgeneral
Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency
GlobeNewswire28 · bearishgeneral
Calidi Biotherapeutics, Inc. (CLDWW) files 8-K
SEC 8-K50 · neutralgeneral
Calidi prices 1.025M shares at $1.17 in registered direct offering
The Fly24 · bearishgeneral
Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering
Business Insider28 · bearishgeneral
Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering
GlobeNewswire28 · bearishgeneral
Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Business Insider56 · neutralproduct/pr
Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire56 · neutralgeneral
CLDI Competitors for Calidi Biotherapeutics Stock
Barchart50 · neutralgeneral
Calidi Biotherapeutics Reports Quarterly Results and Pipeline Progress
TipRanks50 · neutralearnings
Calidi Biotherapeutics GAAP EPS of -$2.94
Seeking Alpha22 · bearishearnings
Calidi Biotherapeutics, Inc. (CLDWW) files 8-K
SEC 8-K50 · neutralgeneral
Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Business Insider63 · neutralproduct/pr
Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire63 · neutralproduct/pr
Calidi Biotherapeutics Implements Reverse Stock Split on NYSE
TipRanks25 · bearishgeneral
Calidi Biotherapeutics, Inc. (CLDWW) files 8-K
SEC 8-K50 · neutralgeneral
Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers
StockTitan56 · neutralproduct/pr
Calidi Announces Reverse Stock Split, Expected to Begin Trading on a 1-for-16 Split Adjusted Basis on July 31, 2026
Business Insider38 · neutralgeneral